登录 | 注册    关注公众号  
微信公众号
搜索
 > 【GRIN2B】

GRIN2B信息

英文名称:Glutamate [NMDA] receptor subunit epsilon 2
中文名称:谷氨酸[NMDA]受体亚基ε-2
靶点别称
上市药物数量:0
临床药物数量:7
最高研发阶段:临床三期

GRIN2B产品咨询

* 此表格只用于收集产品需求咨询,所有信息将严格保密。
                   
ACRO质量管理体系
 
评论(0)
 

GRIN2B 分子别名

NMDAR2B

GRIN2B 分子背景

NMDA receptors (NMDARs) are members of the glutamate-gated ion-channel family that mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation.

GRIN2B 前沿进展

GRIN2B临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定